Hartford, CONNECTICUT4 Active Studies

Lung Cancer Clinical Trials in Hartford, CONNECTICUT

Find 4 actively recruiting lung cancer clinical trials in Hartford, CONNECTICUT. Connect with local research sites and explore new treatment options.

4
Active Trials
2
Sponsors
1,071
Enrolling

Recruiting Lung Cancer Studies in Hartford

RecruitingHartford, CONNECTICUTNCT06732401

Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung Cancer

This phase III trial compares the effect of adding AZD6738 to durvalumab versus durvalumab alone to increase time without cancer in patients with non-small cell lung cancer, following treatment with c...

630 participants
National Cancer Institute (NCI)
View Study Details
RecruitingHartford, CONNECTICUTNCT06498635

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

This phase III trial compares durvalumab to the usual approach (patient observation) after surgery for the treatment of patients with early-stage non-small cell lung cancer. Immunotherapy with monoclo...

306 participants
National Cancer Institute (NCI)
View Study Details
RecruitingHartford, CONNECTICUTNCT05429320

A Study of Local Ablative Therapy (LAT) in People With Non-Small Cell Lung Cancer (NSCLC)

The purpose of this study is to see whether receiving local ablative therapy (LAT) when minimal residual disease/MRD levels are rising can reduce MRD levels and control metastatic non-small cell lung ...

90 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingHartford, CONNECTICUTNCT06287775

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

This phase I/II trial tests the safety, side effects, and best dose of iadademstat when given together with atezolizumab or durvalumab, and studies the effect of the combination in treating patients w...

45 participants
National Cancer Institute (NCI)
View Study Details

About Lung Cancer Clinical Trials in Hartford

Lung cancer is the leading cause of cancer death worldwide, starting in the cells of the lungs. The two main types are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatments include surgery, chemotherapy, radiation, immunotherapy, and targeted drugs.

There are currently 4 lung cancer clinical trials recruiting participants in Hartford, CONNECTICUT. These studies are seeking a combined 1,071 participants. Research is being sponsored by National Cancer Institute (NCI), Memorial Sloan Kettering Cancer Center. Clinical trial participation is free and participants receive study-related medical care at no cost.

Lung Cancer Clinical Trials in Hartford — FAQ

Are there lung cancer clinical trials in Hartford?

Yes, there are 4 lung cancer clinical trials currently recruiting in Hartford, CONNECTICUT. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Hartford?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Hartford research site will contact you about next steps.

Are clinical trials in Hartford free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Hartford studies also compensate for your time and travel.

What lung cancer treatments are being tested?

The 4 active trials in Hartford are testing new therapies including novel drugs, biologics, and treatment approaches for lung cancer.

Data updated March 2, 2026 from ClinicalTrials.gov